Breakthrough of poly(ADP-ribose) polymerase inhibitors (PARPi) resistance treating with the local therapy in recurrent epithelial ovarian cancer patients with oligo-progression
Proceedings of the Biennial Meeting of Asian Society of Gynecologic Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined